A Study in the Treatment of Alcohol Dependence.

NCT00805441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: LY686017
DRUG: Placebo

Sponsor

Eli Lilly and Company